At this time, New York Oncology Hematology does not have access to acquire and administer the new COVID prophylaxis shot Evusheld for immunocompromised patients. We await further guidance from NYS and will keep our patients updated.

About Us

Dr. Resta Interviewed by News Channel 13 About FDA Approval of a New Pancreatic Cancer Drug

11/06/2015

Regina Resta, MD, an NYOH medical oncologist/hematologist, recently spoke with Newschannel 13 health reporter Benita Zahn about FDA approval of a new pancreatic cancer drug, Onyvide. With the region's largest clinical research program, NYOH had two local patients participate in the successful drug trial. 

Ellen Sangedorph, a patient of NYOH’s David Schaffer, MD, Ph.D., was also interviewed. She is currently enrolled in a new clinical trial for kidney cancer. 

Over the past two decades, NYOH patients have participated in more than 500 clinical research trials, leading to 39 FDA approved cancer therapies. 

View the full interview.